NEOGEN CORP

NEOG

In Vitro & In Vivo Diagnostic Substances(MI)CIK: 711377

Revenue (Latest FY)

$822.4M

Net Income (Latest FY)

-$22.9M

Industry

In Vitro & In Vivo Diagnostic Substances

Recent Filings

Company Details

CIK711377

Fiscal Year End0531

CategoryLarge accelerated filer

StateMI

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)